Reply to I.V. Kostopoulos et al

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Jesus F. San-Miguel

Consulting or Advisory Role: Amgen (Inst), Celgene (Inst), Takeda (Inst), Bristol Myers Squibb (Inst), MSD (Inst), Novartis (Inst), Sanofi (Inst), Janssen (Inst), Roche (Inst), AbbVie (Inst), GlaxoSmithKline (Inst), Karyopharm Therapeutics (Inst), Secura Bio (Inst), Regeneron (Inst), Haemalogix (Inst)

Bruno Paiva

Honoraria: Amgen, Bristol Myers Squibb, Celgene, Janssen-Cilag, Takeda, Sanofi, Roche/Genentech, Adaptive Biotechnologies

Consulting or Advisory Role: Celgene, Janssen-Cilag, Sanofi, Takeda

Speakers' Bureau: Celgene

Research Funding: Celgene, Janssen-Cilag, Sanofi, Takeda, Roche/Genentech

No other potential conflicts of interest were reported.